Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 5
2011 11
2012 12
2013 20
2014 28
2015 32
2016 31
2017 31
2018 30
2019 25
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

213 results
Results by year
Filters applied: . Clear all
Page 1
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.
Hsu EC, Rice MA, Bermudez A, Marques FJG, Aslan M, Liu S, Ghoochani A, Zhang CA, Chen YS, Zlitni A, Kumar S, Nolley R, Habte F, Shen M, Koul K, Peehl DM, Zoubeidi A, Gambhir SS, Kunder CA, Pitteri SJ, Brooks JD, Stoyanova T. Hsu EC, et al. Proc Natl Acad Sci U S A. 2020 Jan 28;117(4):2032-2042. doi: 10.1073/pnas.1905384117. Epub 2020 Jan 13. Proc Natl Acad Sci U S A. 2020. PMID: 31932422 Free PMC article.
A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host.
Simons BW, Kothari V, Benzon B, Ghabili K, Hughes R, Zarif J, Ross AE, Hurley PJ, Schaeffer EM. Simons BW, et al. Oncotarget. 2019 Dec 3;10(64):6845-6854. doi: 10.18632/oncotarget.27317. eCollection 2019 Dec 3. Oncotarget. 2019. PMID: 31839878 Free PMC article.
Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience.
Valeriani M, Marinelli L, Macrini S, Reverberi C, Aschelter AM, De Sanctis V, Marchetti P, Tronnolone L, Osti MF. Valeriani M, et al. Radiat Oncol. 2019 Nov 14;14(1):205. doi: 10.1186/s13014-019-1414-x. Radiat Oncol. 2019. PMID: 31727093 Free PMC article.
213 results
Jump to page
Feedback